Silver Book Fact

Every additional dollar spent on newer, less toxic hormonal therapy for breast cancer patients has produced health gains valued at between $27.03 and $36.81.

Murphy, Kevin M. and Robert H. Topel. The Value of Health and Longevity. National Bureau of Economic Research Working Paper. May-2005; 11405. http://www.nber.org/papers/W11405

Reference

Title
The Value of Health and Longevity
Publication
National Bureau of Economic Research Working Paper
Publication Date
May-2005
Authors
Murphy, Kevin M. and Robert H. Topel
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • The 5-year survival rate for all cancers diagnosed between 1995 and 2001 is up from 50% in 1974-1976 to 65%.  
  • According to the Pharmaceutical Research and Manufacturers of America, researchers are currently working on 646 medicines for cancer. All are either in clinical trials or under FDA review. …  
  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in development is designed to induce a powerful immune response to melanoma.  
  • Medicines Prevent Cancer Recurrence: New breast cancer drug greatly reduces recurrence and death (5 to 10 years after diagnosis in postmenopausal women)  
  • Cancer mortality declined more than 2% in 2003, a continuation of the decline that began in 1990.